Đang chuẩn bị liên kết để tải về tài liệu:
TRAITEMENT MEDICAMENTEUX DU DIABETE DE TYPE 2 - PART 8

Bảo vệ tim Nghiên cứu hợp tác Tập đoàn Bảo vệ tim Nghiên cứu về Giảm cholesterol với simvastatin trong 5963 người bị tiểu đường: giả dược kiểm soát ngẫu nhiên dùng thử. 2003 Lancet, 361: 2005-2016 18. Sever PS, Dahlof B, Poulter NR, et al. : Ascot các nhà điều tra. | Traitement medicamenteux du diabete de type 2 Actualisation Argumentaire 17. Heart Protection Study Collaborative Group Heart protection study of cholesterol lowering with simvastatin in 5 963 people with diabetes a randomised placebo-controlled trial. Lancet 2003 361 2005-2016 18. Sever PS Dahlof B Poulter NR et al. ascot investigators. Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations in the Anglo-Scandinavian Cardiac Outcomes Trial--Lipid Lowering Arm ASCOT-LLA a multicentre randomised controlled trial. Lancet. 2003 361 1149-1158. 19. Colhoun HM Thomason MJ Mackness MI et al. Design of the Collaborative AtoRvastatin Diabetes Study CARDS in patients with type 2 diabetes. Collaborative AtoRvastatin Diabetes Study CARDS . Diabet Med. 2002 19 201-211. 20. Colhoun HM Betteridge DJ Durrington PN et al. on behalf of the cards Study investigators. Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study CARDS multicentre randomised placebo-controlled trial. Lancet 2004 364 685-696 21. Shepherd J Blauw GJ Murphy MB et al. PROSPER study group. PROspective Study of Pravastatin in the Elderly at Risk.Pravastatin in elderly individuals at risk of vascular disease PROSPER a randomised controlled trial. Lancet. 2002 360 1623-1630. 21 bis. The FIELD study investigators The need for a large-scale trial of fibrate therapy in diabetes the rationale and design of the Fenofibrate Intervention and Event Lowering in Diabetes FIELD study. 21 ter. The FIELD study investigators Effects of long-term fenofibrate therapy on cardiovascular events in 9 795 people with type 2 diabetes mellitus the FIELD study randomised controlled trial. Lancet 2005 366 1849-1861. 22. Robins SJ Collins D Wittes JT et al. Relation of gemfibrozil treatment and lipid levels with major coronary events VA-HIT a randomized controlled trial. .